Scientist Leverage ReFRAME Drug Repurposing Collection to Confront COVID-19 (IMAGE)

Scripps Research Institute

Scientist Leverage ReFRAME Drug Repurposing Collection to Confront COVID-19

Caption

Calibr established the ReFRAME collection in 2018 with support from the Bill & Melinda Gates Foundation to tackle areas of urgent unmet medical need, especially neglected tropical diseases. The collection has since grown to comprise over 14,000 compounds, including drugs that are already being repurposed for a number of diseases.

Credit

Calibr/Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.